Article
The germline/somatic DNA damage repair gene mutations modulate the therapeutic response in Chinese patients with advanced pancreatic ductal adenocarcinoma.
Journal of translational medicine - 12 Jul 2021
Shui Lin, Li Xiaofen, Peng Yang, Tian Jiangfang, Li Shuangshuang, He Du, Li Ang, Tian Bole, Li Mao, Gao Heli, An Ning, Yi Cheng, Cao Dan
Abstract excerpt
BACKGROUND: Pancreatic ductal adenocarcinoma (PDAC) is a fatal disease with molecular heterogeneity, inducing differences in biological behavior, and therapeutic strategy. NGS profiles of pathogenic alterations in the Chinese PDAC population are limited. We conducted a retrospective study to investigate the predictive role of DNA damage repair (DDR) mutations in precision medicine. METHODS: The NGS profiles were...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
